scorecardresearchBiocon Share Price Live NSE, BSE, Today - Biocon Stock Price

Biocon

BSE: 532523 | NSE: BIOCON | ISIN: INE376G01013 | SECTOR: Biotechnology & Drugs

277.05 3.20 (1.17%)

02 Mar 2024, 06:59 (IST)
  • Open

    276.15
  • High

    278.25
  • Low

    276.15
  • Prev Close

    273.85
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    331.52B
  • Volume

    9.11K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    276.55
  • Ask

    277.05

Company Description

  • Biotechnology & Drugs
  • BSE

    532523
  • NSE

    BIOCON
  • ISIN

    INE376G01013

Biocon Limited is an India-based biopharmaceutical company, which focuses on treating diabetes, cancer and autoimmune diseases. Its segment includes Generics, Biosimilars, Novel Biologics and Research Services. It has developed and commercialized novel biologics, biosimilars, and complex small molecule active pharmaceutical ingredients (APIs) in India and several key global markets, as well as Generic Formulations in the United Sates, Europe and key emerging markets. Its API portfolio includes cardiology, anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology and other key products. Its products include Tacrolimus, Rosuvastatin, Simvastatin, Atorvastatin, Pravastatin, Fingolimod and others. It has over five facilities across Bangalore, Hyderabad and Visakhapatnam in India. Its API manufacturing facilities leverage complex technology platforms that range from microbial fermentation, chromatographic purification, chemical synthesis, peptide synthesis and HPAPIs.

Company Officers

  • Kiran Mazumdarshaw

    Executive Chairperson of the Board
  • Siddharth Mittal

    Chief Executive Officer, Managing Director, Executive Director
  • Indranil Sen

    Chief Financial Officer
  • Peter Bains

    Group Chief Executive Officer
  • Shreehas Tambe

    Chief Executive Officer, Managing Director
  • Mayank Verma

    Compliance Officer, Company Secretary
  • Maninder Puri

    Head, Human Resources
  • Seema Ahuja

    Global Head - Corporate Brand & Head of Communications - EMs
  • Arun Gupta

    Head, Operations
  • Manoj Pananchukunnath

    Head - Research and Development and Regulatory Sciences